1 active not recruiting, 1 completed. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 1, Completed 1 |
| Phase 3 | 1 | Active not recruiting 1 |
Follow Koen Rovers: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PIPAC for Peritoneal Metastases of Colorectal Cancer repetitive ePIPAC-OX - Colorectal Neoplasms, Peritoneal Neoplasms | Phase 2 | Completed | Koen Rovers | 20 | 2017-10-01 | 2019-10-15 |
| Perioperative Systemic Therapy for Isolated Resectable Colorectal Peritoneal Metastases Perioperative systemic therapy, Perioperative CAPOX-bevacizumab, Perioperative FOLFOX-bevacizumab - Colorectal Neoplasm, Colorectal Cancer | Phase 2 / Phase 3 | Active not recruiting | Koen Rovers | 358 | 2017-06-01 | 2026-03-24 |
Colorectal Neoplasms (2) · Peritoneal Neoplasms (2) · Appendiceal Neoplasms (1) · Cecal Neoplasms (1) · Colonic Neoplasms (1) · Drug-Related Side Effects and Adverse Reactions (1) · Hyperthermia (1) · Intraoperative Complications (1) · Neoplasms (1) · Postoperative Complications (1)
Netherlands (2) · Belgium (1)
Alexandra R Brandt-Kerkhof, MD (1) · Arend G Aalbers, MD (1) · Cornelis J Punt, MD, PhD (1) · Djamila Boerma, MD, PhD (1) · Eino B van Duyn, MD, PhD (1) · Ignace H de Hingh, MD, PhD (1) · Ignace de Hingh, MD, PhD (1) · Jurriaan B Tuynman, MD, PhD (1) · Marinus J Wiezer, MD, PhD (1) · Patrick H Hemmer, MD (1) · Pieter J Tanis, MD, PhD (1) · Sandra A Radema, MD, PhD (1) · Wilhemina M van Grevenstein, MD, PhD (1)
PMID 31023318, PMID 31352425, PMID 32572849, PMID 33528867, PMID 33544279, PMID 34009291, PMID 34757489, PMID 37993560, PMID 42372745
2016 (1), 2017 (1)